Baricitinib for the treatment of refractory vascular Behçet's disease.
Wang Z, Wang X, Liu W, Wang Y, Liu J, Zhang L, Zhang S, Tian X, Zhao Y, Zheng W.
Wang Z, et al. Among authors: zhang l, zhang s.
Clin Immunol. 2023 May;250:109298. doi: 10.1016/j.clim.2023.109298. Epub 2023 Mar 24.
Clin Immunol. 2023.
PMID: 36967024